Merck MRK
NYSE MRK
$147.73 -0.73 (-0.49%)
As of: Sep 9, 2026 · 12:01 PM EDT

Merck (MRK) Dividend Coverage Ratio (2009 - 2026)

Merck's (MRK) quarterly Dividend Coverage Ratio came in at 0.62 in Q2 2026, down 129.25% year-over-year from 2.13 in Q2 2025, and up 69.06% quarter-over-quarter from 2.02 in Q1 2026.

Analysis

Merck (MRK) Dividend Coverage Ratio (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Dividend Coverage Ratio for 18 consecutive years, with 0.62 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Dividend Coverage Ratio fell 129.25% year-over-year to 0.62 in Q2 2026; TTM through Jun 2026 was 0.38, a 81.32% decrease from a year earlier, with the FY2025 full-year figure at 2.23, up 2.21% from the prior year.
  • Dividend Coverage Ratio was 0.62 for Q2 2026 at Merck, up from 2.02 in the prior quarter.
  • Over five years, Dividend Coverage Ratio peaked at 2.85 in Q3 2025 and troughed at 3.17 in Q2 2023.
  • A 5-year average of 1.31 and a median of 1.89 in 2022 frame the typical range for Dividend Coverage Ratio.
  • Across the five-year window, Dividend Coverage Ratio slumped 242.0% in 2023 and soared 389.89% in 2024, its largest moves.
  • Over 5 years, Dividend Coverage Ratio stood at 1.72 in 2022, then slumped by 138.39% to 0.66 in 2023, then soared by 389.89% to 1.92 in 2024, then slipped by 23.51% to 1.47 in 2025, then sank by 142.49% to 0.62 in 2026.
  • The last three Dividend Coverage Ratio figures came in at 0.62 (Q2 2026), 2.02 (Q1 2026), and 1.47 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Cover (Qtr)
1 Johnson & Johnson 647.28 Bn 626.53 Bn 17.26 Bn 1.71
2 AbbVie 442.02 Bn 435.45 Bn 12.70 Bn 1.18
3 Merck 364.57 Bn 357.43 Bn 12.21 Bn -0.62
4 Novartis Ag 267.21 Bn 259.52 Bn 11.24 Bn 1.14
5 Pfizer 158.97 Bn 147.27 Bn 10.94 Bn -0.10
6 Sanofi 52.50 Bn 45.12 Bn 10.79 Bn 0.07
7 Revolution Medicines 44.22 Bn 44.22 Bn - -
8 Incyte 25.43 Bn 20.89 Bn 1.57 Bn -
9 United Therapeutics 21.38 Bn 18.72 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.62
Mar 31, 2026 -2.02
Dec 31, 2025 1.47
Sep 30, 2025 2.85
Jun 30, 2025 2.13
Mar 31, 2025 2.48
Dec 31, 2024 1.92
Sep 30, 2024 1.62
Jun 30, 2024 2.75
Mar 31, 2024 2.44
Dec 31, 2023 -0.66
Sep 30, 2023 2.56
Jun 30, 2023 -3.17
Mar 31, 2023 1.52
Dec 31, 2022 1.72
Sep 30, 2022 1.86
Jun 30, 2022 2.23
Mar 31, 2022 2.47
Dec 31, 2021 2.29
Sep 30, 2021 2.77